Managers / Q2 2019 · view latest →
Bluefin Trading, LLC
CIK 0001532351 · 3 PARK AVENUE, 37TH FLOOR, NEW YORK, NY, 10016 · 6469151832
Reported Value
$706M
Q2 2019
Positions
327
Filings on Record
7
2019–present window
Filed
Aug 15, 2019
original filing
Summary
Bluefin Trading, Llc reported $706M in U.S.-listed holdings across 327 positions for Q2 2019.
Its largest position, Array Biopharma, represents 18.3% of the portfolio.
Compared with Q1 2019, the fund opened 108 new positions and exited 108.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 31.4% · $222M
- Other · 26.1% · $184M
- PRIV PLACEMENT · 18.3% · $129M
- ETP · 15.9% · $112M
- ADR · 6.9% · $49M
- Other · 1.4% · $10M
Quarter-over-Quarter Changes full breakdown →
Holdings — Q2 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2020 | $1.2B | 384 | Aug 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $776M | 416 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.5B | 627 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $689M | 512 | Nov 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $706M | 327 | Aug 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $692M | 391 | May 16, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $986M | 417 | Feb 15, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.